Durect Corp (DRRX)

May 23, 2025

Durect Corp stock hits 52-week low at $0.52 amid market challenges - Investing.com Australia

May 23, 2025

May 23, 2025

Durect Corp stock hits 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa

May 23, 2025

May 22, 2025

Durect says ‍on July 24, Impax Laboratories terminated asset transfer and license agreement dated Jan. 3, 2014 - Reuters

May 22, 2025

May 22, 2025

DURECT (NASDAQ:DRRX) Now Covered by Analysts at StockNews.com - Defense World

May 22, 2025

May 15, 2025

Durect: Q1 Earnings Snapshot - New Haven Register

May 15, 2025

May 14, 2025

DURECT (DRRX) Q1 Revenue Surpasses Estimates, Focuses on Phase 3 Trial Funding | DRRX Stock News - GuruFocus

May 14, 2025

May 13, 2025

Durect Corp Q1 2025 Earnings: EPS at -$0.13 Misses Estimate, Rev - GuruFocus

May 13, 2025

May 13, 2025

DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 13, 2025

May 10, 2025

DURECT (DRRX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025

Apr 23, 2025

Durect Corp stock hits 52-week low at $0.69 amid market challenges By Investing.com - Investing.com South Africa

Apr 23, 2025

Apr 23, 2025

Durect Corp stock hits 52-week low at $0.69 amid market challenges - Investing.com

Apr 23, 2025

Apr 22, 2025

Form 8-KCurrent report - ADVFN

Apr 22, 2025

Apr 21, 2025

DURECT Co. (NASDAQ:DRRX) Sees Large Decline in Short Interest - Defense World

Apr 21, 2025

Apr 20, 2025

DURECT (NASDAQ:DRRX) Now Covered by StockNews.com - Defense World

Apr 20, 2025

Apr 12, 2025

StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX) - Defense World

Apr 12, 2025

Apr 09, 2025

Durect Corp stock hits 52-week low at $0.7 amid market challenges - Investing.com Canada

Apr 09, 2025

Apr 04, 2025

DURECT (NASDAQ:DRRX) Coverage Initiated at StockNews.com - Defense World

Apr 04, 2025

Mar 31, 2025

DURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call Transcript - MSN

Mar 31, 2025

Mar 28, 2025

Here's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn Situation - Yahoo Finance

Mar 28, 2025

Mar 27, 2025

DURECT Corporation’s Earnings Call Highlights Cost Cuts and Breakthrough Potential - TipRanks

Mar 27, 2025

Mar 27, 2025

Durect Corp Q4 2024 Earnings: EPS of $0.25 Surpasses Estimates, Revenue Falls Short at $0.5 Million - GuruFocus

Mar 27, 2025

Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic Focus Amid Financial Challenges - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic F - GuruFocus.com

Mar 27, 2025

Mar 26, 2025

Durect: Q4 Earnings Snapshot - MySA

Mar 26, 2025

Mar 26, 2025

Durect reports Q4 cont ops EPS (6c), consensus (2c) - TipRanks

Mar 26, 2025

Mar 26, 2025

Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 26, 2025

Mar 26, 2025

Earnings call transcript: Durect’s Q4 2024 revenue drops as focus shifts to key drug - Investing.com India

Mar 26, 2025

Mar 26, 2025

DURECT Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025

Mar 26, 2025

DURECT Transforms Business: $17.5M Asset Sale, NEJM Evidence Validates Key Drug Program - Stock Titan

Mar 26, 2025

Mar 26, 2025

Earnings Scheduled For March 26, 2025 - Benzinga

Mar 26, 2025

Mar 25, 2025

What To Expect From Durect Corp (DRRX) Q4 2024 Earnings - GuruFocus

Mar 25, 2025

Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 - GuruFocus.com

Mar 19, 2025

Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - Quantisnow

Mar 19, 2025

Mar 19, 2025

DURECT (DRRX) to Release Quarterly Earnings on Wednesday - Defense World

Mar 19, 2025

Mar 19, 2025

StockNews.com Begins Coverage on DURECT (NASDAQ:DRRX) - Defense World

Mar 19, 2025

Mar 15, 2025

DURECT Corporation (NASDAQ:DRRX) Is Expected To Breakeven In The Near Future - Simply Wall St

Mar 15, 2025